Business
Neuren announces A$50m on-market share buy-back program
Neuren announces A$50m on-market share buy-back program
About this update from Neuren Pharmaceuticals Limited
[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":252,"tagName":"div"}]